Drug repurposing in NCDs: benefits and challenges

Drug repurposing in NCDs: benefits and challenges

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Бібліографічні деталі
Автор:	Nasir, Naushin Sadia
Інші автори:	Kabir, Eva Rahman
Формат:	Дисертація
Мова:	English
Опубліковано:	Brac University 2021
Предмети:	Drug repurposing Noncommunicable disease Market and data exclusivity Benefits and challenges Communicable diseases Chronic diseases > Treatment Drug development
Онлайн доступ:	http://hdl.handle.net/10361/15764

Схожі ресурси

A review on drug repurposing for diabetes epidemic
за авторством: Lamia, Sadia Raisa
Опубліковано: (2022)

Drug Repurposing : search for a drug having effective anticancer activity
за авторством: Khan, Md. Arafat
Опубліковано: (2018)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
за авторством: Chakraborty, Anuradha
Опубліковано: (2024)

A comprehensive review on drug repurposing in cancer treatment
за авторством: Sarkar, Onusree
Опубліковано: (2024)

A review on cellular senescence and prospect of Senolytic drugs against chronic age-related diseases
за авторством: Tasnim, Saida Masuma
Опубліковано: (2021)

Drug repurposing: search for targeted drug candidates in the treatment of HER2 positive breast cancer
за авторством: Yeasmin, Jahida
Опубліковано: (2024)

Molecular docking of Fluvastatin and Teneligliptin targeting AT1R in hypertension
за авторством: Jahan, Esrat
Опубліковано: (2020)

The illness narratives : suffering, healing, and the human condition /
за авторством: Kleinman, Arthur
Опубліковано: (1988)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
за авторством: Tamanna, Mst. Taskia
Опубліковано: (2023)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
за авторством: Oishy, Jannatun Noor
Опубліковано: (2024)

An overview on Covid-19 and invention of its treatment by drugs
за авторством: Nawer, Anika
Опубліковано: (2022)

Health practices among rural adults regarding prevention of Hypertension
за авторством: Zeba, Suhala Ashraf, та інші
Опубліковано: (2024)

The world health report 1997: conquering suffering, enriching humanity : report of the Director-General.
Опубліковано: (1997)

The world health report 1996 : fighting disease, fostering development : report of the Director-General.
Опубліковано: (1996)

Evolution of Superbugs: a lethal bioterror
за авторством: Hossain, Md Abir
Опубліковано: (2020)

A review on the therapeutic design and challenges of potential COVID-19 vaccines
за авторством: Ziad, Ahmed
Опубліковано: (2021)

Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017
за авторством: GBD Chronic Kidney Disease Collaboration
Опубліковано: (2022)

Bangladesh health system in transition: selected articles
за авторством: Islam, Anwar
Опубліковано: (2010)

Prevalence of chronic kidney disease in South Asia: A systematic review
за авторством: Hasan, Mehedi, та інші
Опубліковано: (2022)

Socio-economic inequality of chronic non-communicable diseases in Bangladesh
за авторством: Biswas, Tuhin, та інші
Опубліковано: (2018)

Microneedle mediated approaches in Ocular drug delivery
за авторством: Ahmed, Tanvir
Опубліковано: (2022)

The prevalence of multi-drug-resistant staphylococcus aureus and klebsiella pneumoniae in cooked meat samples collected from hospital cafeterias in the Dhaka city corporation area
за авторством: Hoque, Mahmuda, та інші
Опубліковано: (2024)

A review on potential anticancer properties of antidiabetic drugs: metformin and sulfonylureas
за авторством: Hossain, Tamara
Опубліковано: (2024)

A study on drug product approval by the FDA from 1930 to 2019
за авторством: Jony, Md. Nazmul Islam
Опубліковано: (2023)

Determining fatal heart failure risks in patients diagnosed with chronic kidney disease: a machine learning approach
за авторством: Haque, Adiba, та інші
Опубліковано: (2022)

A review on the rare diseases and subsequent orphan drugs
за авторством: Oishi, Nuzhat Anjum
Опубліковано: (2024)

A new social sciences network for infectious threats
за авторством: Giles-Vernick, Tamara, та інші
Опубліковано: (2022)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
за авторством: Jahan, Nusrat
Опубліковано: (2023)

Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
за авторством: Mehreen, Elnaj
Опубліковано: (2021)

In-hospital outcome of Diabetes patients with Chronic Kidney Disease
за авторством: Kabir, Sabrina
Опубліковано: (2021)

Overweight and obesity among children and adolescents in Bangladesh: a systematic review and meta-analysis
за авторством: Biswas, Tuhin, та інші
Опубліковано: (2018)

Importance of biologics in rheumatoid arthritis management
за авторством: Riyadh, S. M.
Опубліковано: (2022)

Hypovitaminosis D: a modifiable risk factor for noncommunicable diseases
за авторством: Hossain, Afrin
Опубліковано: (2024)

Sales & marketing challenges of Bproperty.com Ltd during Covid-19
за авторством: Sabur, Md. Monjur Alam
Опубліковано: (2023)

Role of statins as antagonists of 1DHF in cancer
за авторством: Mustafa, Nashrah
Опубліковано: (2018)

Role of protein’s and future treatment options for Alzheimer’s Disease
за авторством: Islam, Md. Irfath
Опубліковано: (2023)

Prevalence and associated risk factors of anxiety among university students of Bangladesh residing in urban areas
за авторством: Muskan, Faiza Fairuz
Опубліковано: (2024)

Herbal drugs used in to cure different types of skin disorders
за авторством: Rahman, Farhana
Опубліковано: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
за авторством: Afsana, Nourin
Опубліковано: (2022)

Currently available dosage forms and the route of administration of drugs for COVID-19 treatments
за авторством: Ahmed, Hummam Abrar
Опубліковано: (2023)